These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 2040687
1. Lipopolysaccharide from Escherichia coli reduces antigen-induced bronchoconstriction in actively sensitized guinea pigs. Vannier E, Lefort J, Lellouch-Tubiana A, Terlain B, Vargaftig BB. J Clin Invest; 1991 Jun; 87(6):1936-44. PubMed ID: 2040687 [Abstract] [Full Text] [Related]
2. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade. Boukili MA, Bureau M, Lagente V, Lefort J, Lellouch-Tubiana A, Malanchère E, Vargaftig BB. Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407 [Abstract] [Full Text] [Related]
3. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung. Bureau MF, De Clerck F, Lefort J, Arreto CD, Vargaftig BB. J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127 [Abstract] [Full Text] [Related]
4. Active immunization induces lung hyperresponsiveness in the guinea pig. Pharmacologic modulation and triggering role of the booster injection. Pretolani M, Lefort J, Vargaftig BB. Am Rev Respir Dis; 1988 Dec; 138(6):1572-8. PubMed ID: 3202509 [Abstract] [Full Text] [Related]
5. Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs. Pretolani M, Lefort J, Venco C, Perrisoud D, Vargaftig BB. Eur J Pharmacol; 1992 Jun 05; 216(2):141-7. PubMed ID: 1397002 [Abstract] [Full Text] [Related]
6. Alveolar macrophages and eicosanoids but not neutrophils, mediate bronchoconstriction induced by FMLP in the guinea-pig. Boukili MA, Bureau MF, Lellouch-Tubiana A, Lefort J, Simon MT, Vargaftig BB. Br J Pharmacol; 1989 Sep 05; 98(1):61-70. PubMed ID: 2508985 [Abstract] [Full Text] [Related]
7. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. Desquand S, Lefort J, Dumarey C, Vargaftig BB. Br J Pharmacol; 1991 Mar 05; 102(3):687-95. PubMed ID: 1285397 [Abstract] [Full Text] [Related]
8. Interference by the novel PAF-acether antagonist WEB 2086 with the bronchopulmonary responses to PAF-acether and to active and passive anaphylactic shock in guinea-pigs. Pretolani M, Lefort J, Malanchère E, Vargaftig BB. Eur J Pharmacol; 1987 Aug 21; 140(3):311-21. PubMed ID: 3653247 [Abstract] [Full Text] [Related]
14. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs. Lin CH, Ko FN, Ishii H, Ishikawa T, Chen IS, Teng CM, Kuo HP. Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb 21; 355(2):210-6. PubMed ID: 9050014 [Abstract] [Full Text] [Related]
15. Protection by nedocromil sodium of active immunization-induced bronchopulmonary alterations in the guinea pig. Pretolani M, Lefort J, Silva P, Malanchere E, Dumarey C, Bachelet M, Vargaftig BB. Am Rev Respir Dis; 1990 May 21; 141(5 Pt 1):1259-65. PubMed ID: 2160213 [Abstract] [Full Text] [Related]
20. Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion. da Motta JI, Cunha FQ, Vargaftig BB, Ferreira SH. Br J Pharmacol; 1994 May 21; 112(1):111-6. PubMed ID: 8032630 [Abstract] [Full Text] [Related] Page: [Next] [New Search]